Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Brandes, Alina
Sinner, Moritz F.
Kääb, Stefan
and
Rogowski, Wolf H.
2015.
Early decision-analytic modeling – a case study on vascular closure devices.
BMC Health Services Research,
Vol. 15,
Issue. 1,
Markiewicz, Katarzyna
van Til, Janine A.
Steuten, Lotte M.G.
and
IJzerman, Maarten J.
2016.
Commercial viability of medical devices using Headroom and return on investment calculation.
Technological Forecasting and Social Change,
Vol. 112,
Issue. ,
p.
338.
Middelkamp, Heleen H.T.
van der Meer, Andries D.
Hummel, J. Marjan
Stamatialis, Dimitrios F.
Mummery, Christine L.
Passier, Robert
and
IJzerman, Maarten J.
2016.
Organs-on-Chips in Drug Development: The Importance of Involving Stakeholders in Early Health Technology Assessment.
Applied In Vitro Toxicology,
Vol. 2,
Issue. 2,
p.
74.
Huygens, Simone A
Rutten-van Mölken, Maureen P M H
Bekkers, Jos A
Bogers, Ad J J C
Bouten, Carlijn V C
Chamuleau, Steven A J
de Jaegere, Peter P T
Kappetein, Arie Pieter
Kluin, Jolanda
van Mieghem, Nicolas M D A
Versteegh, Michel I M
Witsenburg, Maarten
and
Takkenberg, Johanna J M
2016.
Conceptual model for early health technology assessment of current and novel heart valve interventions.
Open Heart,
Vol. 3,
Issue. 2,
p.
e000500.
Alshreef, Abualbishr
Jenks, Michelle
Green, William
and
Dixon, Simon
2016.
Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
Applied Health Economics and Health Policy,
Vol. 14,
Issue. 6,
p.
623.
Migliore, Antonio
2016.
Technology assessment of innovative medical devices in Europe.
Expert Review of Medical Devices,
Vol. 13,
Issue. 3,
p.
217.
Vaquero Martín, María
Reinhardt, Ronny
and
Gurtner, Sebastian
2016.
Stakeholder integration in new product development: a systematic analysis of drivers and firm capabilities.
R&D Management,
Vol. 46,
Issue. S3,
p.
1095.
IJzerman, Maarten J.
Koffijberg, Hendrik
Fenwick, Elisabeth
and
Krahn, Murray
2017.
Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature.
PharmacoEconomics,
Vol. 35,
Issue. 7,
p.
727.
Rogalewicz, Vladimír
and
Barták, Miroslav
2017.
Controversies around QALYs.
Vnitřní lékařství,
Vol. 63,
Issue. 4,
p.
242.
Fasterholdt, Iben
Krahn, Murray
Kidholm, Kristian
Yderstræde, Knud Bonnet
and
Pedersen, Kjeld Møller
2017.
Review of early assessment models of innovative medical technologies.
Health Policy,
Vol. 121,
Issue. 8,
p.
870.
Wissing, Tamar B.
Bonito, Valentina
Bouten, Carlijn V. C.
and
Smits, Anthal I. P. M.
2017.
Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective.
npj Regenerative Medicine,
Vol. 2,
Issue. 1,
Miquel-Cases, Anna
Schouten, Philip C.
Steuten, Lotte M.G.
Retèl, Valesca P.
Linn, Sabine C.
and
van Harten, Wim H.
2017.
(Very) Early technology assessment and translation of predictive biomarkers in breast cancer.
Cancer Treatment Reviews,
Vol. 52,
Issue. ,
p.
117.
Greenhalgh, Trisha
Fahy, Nick
and
Shaw, Sara
2017.
The Bright Elusive Butterfly of Value in Health Technology Development Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".
International Journal of Health Policy and Management,
Vol. 7,
Issue. 1,
p.
81.
Greenhalgh, Trisha
Wherton, Joseph
Papoutsi, Chrysanthi
Lynch, Jennifer
Hughes, Gemma
A'Court, Christine
Hinder, Susan
Fahy, Nick
Procter, Rob
and
Shaw, Sara
2017.
Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies.
Journal of Medical Internet Research,
Vol. 19,
Issue. 11,
p.
e367.
Fiedler, B.A.
2017.
Managing Medical Devices Within a Regulatory Framework.
p.
179.
Lehoux, Pascale
Miller, Fiona A.
Daudelin, Geneviève
and
Denis, Jean-Louis
2017.
Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.
International Journal of Health Policy and Management,
Vol. 6,
Issue. 9,
p.
509.
Horgan, Denis
2017.
Treatment Is Worth a Lot - But Just How Much.
Biomedicine Hub,
Vol. 2,
Issue. Suppl. 1,
p.
1.
Olry de Labry Lima, Antonio
Espín Balbino, Jaime
Lemgruber, Alexandre
Caro Martínez, Araceli
García-Mochón, Leticia
Martín Ruiz, Eva
and
Lessa, Fernanda
2017.
Health technology assessment process of a cardiovascular medical device in four different settings.
Journal of Comparative Effectiveness Research,
Vol. 6,
Issue. 7,
p.
591.
Manetti, Stefania
Burns, Richeal M.
and
Turchetti, Giuseppe
2018.
EMBEC & NBC 2017.
Vol. 65,
Issue. ,
p.
631.
Jørgensen, Tanja S.
Skougaard, Marie
Taylor, Peter C.
Asmussen, Hans C.
Lee, Anne
Klokker, Louise
Svejstrup, Louise
Mountian, Irina
Gudbergsen, Henrik
and
Kristensen, Lars Erik
2018.
The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases.
The Patient - Patient-Centered Outcomes Research,
Vol. 11,
Issue. 5,
p.
515.